Skip to main content

Table 2 Significant differentially expressed miRNA profile in UA patients treated with or without statin

From: Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina

Whole blood Score(d) Fold change q-value(%) Plasma Score(d) Fold change q-value(%)
hsa-miR-191 3.9826 2.0182 <0.0001% hsa-miR-21 4.0676 9.6700 <0.0001%
hsa-miR-92a 3.8634 2.6235 <0.0001% hsa-miR-223 3.4159 8.6072 <0.0001%
hsa-miR-532-3p 3.3904 2.4110 <0.0001% hsa-miR-106a 3.1782 5.9014 <0.0001%
hsa-miR-574-3p 3.1517 2.7277 <0.0001% hsa-miR-17 3.0701 5.7191 <0.0001%
hsa-miR-30b 3.0671 2.2520 <0.0001% hsa-miR-320 2.7697 7.9742 <0.0001%
hsa-miR-486-5p 3.0474 2.2180 <0.0001% hsa-miR-24 2.5543 5.1630 <0.0001%
hsa-miR-223 3.0328 2.3800 <0.0001% hsa-miR-146b-5p 2.4747 16.9902 <0.0001%
hsa-miR-30c 2.9640 2.1134 <0.0001% hsa-miR-142-3p 2.4040 16.8645 <0.0001%
hsa-miR-484 2.9314 2.4529 <0.0001% hsa-miR-19b 2.3810 7.1494 <0.0001%
hsa-miR-451 2.8041 3.1920 <0.0001% hsa-miR-19a 2.2580 9.1338 <0.0001%
hsa-miR-331-3p 2.6506 1.8440 <0.0001% hsa-miR-30a-5 2.1183 9.2122 <0.0001%
hsa-miR-25 2.6181 2.3039 <0.0001% hsa-miR-222 2.0399 8.4189 <0.0001%
hsa-miR-222 2.5022 2.0910 <0.0001% hsa-miR-126 2.0359 7.1429 <0.0001%
hsa-miR-652 2.4739 2.4337 <0.0001% hsa-miR-451 1.9745 9.8249 <0.0001%
hsa-miR-19b 2.4250 2.0244 <0.0001% hsa-miR-197 1.9738 2.7519 <0.0001%
hsa-miR-15b 2.2769 2.2809 <0.0001% hsa-miR-92a 1.9470 6.4763 <0.0001%
hsa-miR-140-3p 2.2018 1.9416 <0.0001% hsa-miR-20a 1.9312 6.8796 <0.0001%
hsa-miR-26a 2.1192 2.3774 <0.0001% hsa-miR-29a 1.8389 4.4884 <0.0001%
hsa-miR-324-3p 2.1131 1.8923 <0.0001% hsa-miR-146a 1.7932 7.7389 <0.0001%
hsa-miR-150 2.0946 1.7147 <0.0001%     
hsa-miR-93 2.0697 2.4706 <0.0001%     
hsa-miR-106a 2.0101 2.2727 <0.0001%     
  1. 22 whole blood miRNAs and 19 plasma miRNAs were significantly different between the statin treatment group and the control group.